Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.1 trillion and total revenue of $105.3 billion.
Market Cap
1.1T
Revenue
105.3B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-39.26%
Dividend Yield
0.05%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.98B | - | 2,047,432 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 75.21B | - | 1,680,953 | 14.25B |
| 3 | ARGX | argenx SE | 47.98B | - | 440,211 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.46B | - | 1,527,371 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.42B | - | 153,661 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.43B | - | 3,676,482 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.35B | - | 1,192,472 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.25B | - | 4,798,651 | - |
| 9 | RPRX | Royalty Pharma plc | 22.83B | - | 1,982,260 | 2.35B |
| 10 | INCY | Incyte Corporation | 20.85B | - | 1,696,253 | 4.81B |
| 11 | GMAB | Genmab A/S | 19.62B | -4.73% | 6,249,088 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 16.34B | 6.28% | 11,890,786 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 16.09B | - | 8,170,037 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.70B | - | 7,388,848 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.14B | -1.33% | 2,027,453 | - |
| 16 | ASND | Ascendis Pharma A/S | 12.63B | - | 693,068 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.36B | - | 3,023,389 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.83B | - | 2,898,586 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.39B | - | 276,250 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | - | 1,447,968 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.70B | - | 3,533,956 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.49B | - | 2,076,438 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.29B | - | 1,110,381 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.15B | 0.26% | 779,682 | 6.23M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.94B | - | 618,952 | 561.26M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 8.80B | 6.55% | 564,226 | 7.46M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.77B | - | 1,573,267 | 829.45M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.37B | - | 1,271,582 | 1.24B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.27B | - | 278,828 | 373.16M |
| 30 | NUVL | Nuvalent, Inc. | 8.10B | - | 361,160 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.65B | - | 1,234,063 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.56B | - | 2,298,536 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.78B | -4.18% | 507,977 | 174.33M |
| 34 | GPCR | Structure Therapeutics Inc. | 6.13B | - | 1,623,455 | - |
| 35 | PCVX | Vaxcyte, Inc. | 6.10B | - | 976,296 | - |
| 36 | COGT | Cogent Biosciences, Inc. | 5.92B | - | 2,312,544 | - |
| 37 | PTCT | PTC Therapeutics, Inc. | 5.82B | - | 1,044,041 | 1.78B |
| 38 | BLTE | Belite Bio, Inc | 5.82B | - | 159,479 | - |
| 39 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.74B | - | 776,565 | 1.54M |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.56B | - | 661,883 | 43.74M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.45B | - | 392,949 | - |
| 42 | IBRX | ImmunityBio, Inc. | 5.44B | 39.75% | 182,288,197 | 82.56M |
| 43 | IMVT | Immunovant, Inc. | 5.32B | - | 1,678,281 | - |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.13B | -3.26% | 664,933 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.10B | -1.29% | 1,409,252 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.95B | - | 411,300 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.71B | - | 336,130 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.59B | - | 875,652 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.47B | - | 2,499,003 | 531.90M |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.43B | 0.14% | 3,535,615 | 598.70M |
| 51 | CGON | CG Oncology, Inc. | 4.41B | - | 1,054,478 | 2.17M |
| 52 | ACAD | ACADIA Pharmaceuticals Inc. | 4.40B | - | 1,357,728 | 1.05B |
| 53 | ADMA | ADMA Biologics, Inc. | 4.12B | - | 2,186,251 | 488.56M |
| 54 | LEGN | Legend Biotech Corporation | 4.09B | - | 1,688,651 | 909.05M |
| 55 | ACLX | Arcellx, Inc. | 3.99B | - | 573,599 | 35.90M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 3.98B | - | 1,918,763 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.83B | - | 3,693,447 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.80B | - | 219,807 | 251.23M |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.65B | -1.86% | 2,416,137 | 741.17M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.59B | - | 466,184 | 35.24M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.30B | 0.50% | 859,035 | - |
| 62 | LQDA | Liquidia Corporation | 3.30B | -2.22% | 3,325,688 | 69.22M |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.24B | - | 1,680,999 | 15.00M |
| 64 | VRDN | Viridian Therapeutics, Inc. | 3.17B | - | 1,195,626 | 70.79M |
| 65 | ARQT | Arcutis Biotherapeutics, Inc. | 3.17B | - | 1,110,987 | 317.93M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.14B | - | 820,595 | 214.83M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.09B | - | 1,003,551 | 7.50M |
| 68 | BEAM | Beam Therapeutics Inc. | 3.08B | -2.59% | 1,613,367 | 55.70M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | - | 1,174,539 | 366.10M |
| 70 | ALMS | Alumis Inc. | 2.97B | -1.28% | 1,580,239 | 22.12M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.90B | - | 1,448,559 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 2.81B | - | 1,386,339 | - |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.79B | - | 892,820 | 578.20M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.75B | - | 1,963,953 | - |
| 75 | ERAS | Erasca, Inc. | 2.73B | - | 11,686,648 | - |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.70B | - | 1,195,233 | 240.00M |
| 77 | IRON | Disc Medicine, Inc. | 2.68B | - | 454,807 | - |
| 78 | ADPT | Adaptive Biotechnologies Corporation | 2.67B | - | 1,042,637 | 252.75M |
| 79 | TLX | Telix Pharmaceuticals Limited | 2.61B | - | 178,854 | 664.23M |
| 80 | MLYS | Mineralys Therapeutics, Inc. | 2.59B | - | 1,379,614 | - |
| 81 | SYRE | Spyre Therapeutics, Inc. | 2.58B | - | 439,333 | - |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.52B | - | 2,257,637 | 1.02B |
| 83 | WVE | Wave Life Sciences Ltd. | 2.50B | - | 3,701,972 | 109.23M |
| 84 | TVTX | Travere Therapeutics, Inc. | 2.49B | - | 2,221,370 | 435.83M |
| 85 | IMNM | Immunome, Inc. | 2.47B | - | 1,956,300 | 9.68M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.43B | 0.65% | 21,419,341 | 43.69M |
| 87 | AAPG | Ascentage Pharma Group International | 2.40B | - | 4,594 | 54.52M |
| 88 | OCUL | Ocular Therapeutix, Inc. | 2.40B | -0.09% | 6,653,359 | 55.78M |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.28B | 1.26% | 1,169,594 | 98.68M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | -0.84% | 2,269,513 | 2.41B |
| 91 | MESO | Mesoblast Limited | 2.20B | - | 148,251 | 17.20M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.17B | -4.30% | 1,900,763 | 630.60M |
| 93 | OLMA | Olema Pharmaceuticals, Inc. | 2.13B | - | 872,235 | - |
| 94 | GLPG | Galapagos NV | 2.10B | 0.04% | 154,250 | 336.64M |
| 95 | HRMY | Harmony Biosciences Holdings, Inc. | 2.09B | - | 648,690 | 825.94M |
| 96 | ZLAB | Zai Lab Limited | 2.07B | - | 516,016 | 441.63M |
| 97 | NUVB | Nuvation Bio Inc. | 2.01B | -4.72% | 5,397,409 | 26.75M |
| 98 | MAZE | Maze Therapeutics, Inc. | 1.96B | 2.41% | 229,675 | 2.50M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | - | 1,215,351 | 265.81M |
| 100 | NRIX | Nurix Therapeutics, Inc. | 1.95B | - | 1,398,904 | 83.69M |
| 101 | VCEL | Vericel Corporation | 1.89B | - | 427,212 | 258.72M |
| 102 | DNTH | Dianthus Therapeutics, Inc. | 1.89B | - | 638,640 | 3.08M |
| 103 | GLUE | Monte Rosa Therapeutics, Inc. | 1.88B | - | 866,725 | 181.54M |
| 104 | NBY | NovaBay Pharmaceuticals, Inc. | 1.86B | - | 2,783,458 | 10.30M |
| 105 | MBX | MBX Biosciences, Inc. | 1.82B | - | 504,308 | - |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | - | 705,151 | 111.30M |
| 107 | ZYME | Zymeworks Inc. | 1.76B | - | 525,766 | 134.48M |
| 108 | TNGX | Tango Therapeutics, Inc. | 1.75B | - | 5,995,206 | 66.50M |
| 109 | SION | Sionna Therapeutics, Inc. | 1.75B | - | 264,890 | - |
| 110 | BHVN | Biohaven Ltd. | 1.74B | - | 4,125,889 | - |
| 111 | CLDX | Celldex Therapeutics, Inc. | 1.70B | - | 675,539 | 2.60M |
| 112 | IMCR | Immunocore Holdings plc | 1.69B | - | 588,084 | 379.59M |
| 113 | KOD | Kodiak Sciences Inc. | 1.68B | 1.69% | 706,932 | - |
| 114 | UPB | Upstream Bio, Inc. | 1.68B | - | 418,416 | 2.80M |
| 115 | ARDX | Ardelyx, Inc. | 1.64B | - | 4,332,329 | 398.23M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.64B | - | 1,138,367 | 205.63M |
| 117 | PHVS | Pharvaris N.V. | 1.63B | - | 225,186 | - |
| 118 | ORKA | Oruka Therapeutics, Inc. | 1.62B | - | 718,516 | - |
| 119 | MNKD | MannKind Corporation | 1.60B | -6.63% | 6,740,900 | 313.79M |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.59B | - | 975,813 | 44.79M |
| 121 | ELVN | Enliven Therapeutics, Inc. | 1.59B | - | 1,239,900 | - |
| 122 | PGEN | Precigen, Inc. | 1.56B | - | 3,634,228 | 6.31M |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.54B | - | 317,224 | - |
| 124 | FTRE | Fortrea Holdings Inc. | 1.52B | - | 1,945,718 | 2.76B |
| 125 | OCS | Oculis Holding AG | 1.46B | - | 431,478 | 992.00K |
| 126 | INVA | Innoviva, Inc. | 1.45B | - | 558,430 | 388.52M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.45B | 5.31% | 5,749,003 | 57.53M |
| 128 | QURE | uniQure N.V. | 1.42B | 3.91% | 1,572,108 | 15.75M |
| 129 | SVRA | Savara Inc. | 1.40B | - | 1,651,661 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 1.34B | - | 1,159,819 | - |
| 131 | ATAI | AtaiBeckley Inc. | 1.32B | -1.89% | 2,115,744 | 3.02M |
| 132 | IMTX | Immatics N.V. | 1.32B | - | 454,229 | 99.45M |
| 133 | NVAX | Novavax, Inc. | 1.30B | 2.96% | 5,448,522 | 1.06B |
| 134 | DBVT | DBV Technologies S.A. | 1.29B | - | 662,346 | 5.50M |
| 135 | RAPP | Rapport Therapeutics, Inc. | 1.28B | - | 215,821 | - |
| 136 | RLAY | Relay Therapeutics, Inc. | 1.27B | - | 2,949,781 | 8.36M |
| 137 | ANAB | AnaptysBio, Inc. | 1.26B | - | 371,063 | 169.47M |
| 138 | CAPR | Capricor Therapeutics, Inc. | 1.26B | - | 985,386 | 11.13M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.25B | - | 3,710,629 | 6.31M |
| 140 | EYPT | EyePoint, Inc. | 1.25B | -4.80% | 882,550 | 42.34M |
| 141 | XERS | Xeris Biopharma Holdings, Inc. | 1.25B | - | 1,618,668 | 266.14M |
| 142 | ABCL | AbCellera Biologics Inc. | 1.23B | -1.44% | 5,382,638 | 35.33M |
| 143 | SANA | Sana Biotechnology, Inc. | 1.22B | - | 2,779,191 | - |
| 144 | PHAR | Pharming Group N.V. | 1.21B | 1.54% | 17,891 | 362.27M |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.20B | 2.51% | 1,463,500 | - |
| 146 | IVA | Inventiva S.A. | 1.18B | - | 388,252 | 19.93M |
| 147 | PVLA | Palvella Therapeutics, Inc. | 1.18B | - | 252,809 | - |
| 148 | ORIC | ORIC Pharmaceuticals, Inc. | 1.18B | - | 1,808,231 | - |
| 149 | SEPN | Septerna, Inc. | 1.17B | - | 344,108 | 22.05M |
| 150 | PHAT | Phathom Pharmaceuticals, Inc. | 1.10B | - | 1,512,686 | 147.19M |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.08B | - | 699,535 | 15.00M |
| 152 | GHRS | GH Research PLC | 1.05B | - | 182,476 | - |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.05B | - | 252,853 | 1.40M |
| 154 | SPRY | ARS Pharmaceuticals, Inc. | 1.05B | - | 1,095,621 | 142.77M |
| 155 | DAWN | Day One Biopharmaceuticals, Inc. | 1.04B | - | 4,168,697 | 133.67M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.04B | - | 319,324 | 5.56M |
| 157 | NBTX | Nanobiotix S.A. | 1.02B | - | 13,553 | 11.93M |
| 158 | TBPH | Theravance Biopharma, Inc. | 1.01B | - | 266,888 | 80.33M |
| 159 | CMPX | Compass Therapeutics, Inc. | 1.01B | - | 1,769,633 | 850.00K |
| 160 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.00B | - | 1,494,494 | 192.44M |
| 161 | VTYX | Ventyx Biosciences, Inc. | 996.61M | - | 1,925,875 | - |
| 162 | RAPT | RAPT Therapeutics, Inc. | 972.65M | 9.04% | 430,144 | - |
| 163 | IOVA | Iovance Biotherapeutics, Inc. | 936.84M | - | 23,431,207 | 250.43M |
| 164 | BCAX | Bicara Therapeutics Inc. | 917.60M | - | 463,900 | - |
| 165 | XNCR | Xencor, Inc. | 913.34M | - | 673,540 | 150.13M |
| 166 | CTMX | CytomX Therapeutics, Inc. | 913.26M | 26.82% | 13,388,979 | 113.63M |
| 167 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 913.07M | - | 197,876 | - |
| 168 | ANNX | Annexon, Inc. | 904.77M | - | 1,616,772 | - |
| 169 | URGN | UroGen Pharma Ltd. | 880.01M | - | 1,012,855 | 96.52M |
| 170 | AVBP | ArriVent BioPharma, Inc. | 861.13M | - | 423,378 | - |
| 171 | DRUG | Bright Minds Biosciences Inc. | 859.74M | - | 129,353 | - |
| 172 | VALN | Valneva SE | 851.63M | 0.20% | 3,130 | 211.09M |
| 173 | OMER | Omeros Corporation | 851.51M | - | 2,680,080 | - |
| 174 | VIR | Vir Biotechnology, Inc. | 843.10M | - | 1,672,416 | 16.86M |
| 175 | GERN | Geron Corporation | 836.25M | - | 13,263,857 | 183.40M |
| 176 | JANX | Janux Therapeutics, Inc. | 827.63M | - | 1,762,194 | 10.00M |
| 177 | MDXG | MiMedx Group, Inc. | 802.71M | - | 1,540,773 | 393.44M |
| 178 | YDES | YD Bio Limited | 796.02M | - | 28,550 | 510.36K |
| 179 | ARVN | Arvinas, Inc. | 783.54M | - | 645,012 | 312.30M |
| 180 | ABUS | Arbutus Biopharma Corporation | 780.84M | - | 8,509,289 | 14.61M |
| 181 | NKTR | Nektar Therapeutics | 766.47M | - | 674,038 | 62.60M |
| 182 | MPLT | MapLight Therapeutics, Inc. | 741.90M | - | 293,860 | - |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 737.98M | - | 1,159,766 | 1.43M |
| 184 | KURA | Kura Oncology, Inc. | 736.17M | - | 2,301,574 | 104.03M |
| 185 | ATXS | Astria Therapeutics, Inc. | 711.85M | - | 1,331,272 | 706.00K |
| 186 | PRME | Prime Medicine, Inc. | 704.61M | - | 3,691,862 | 5.98M |
| 187 | GYRE | Gyre Therapeutics, Inc. | 698.04M | - | 34,845 | 107.27M |
| 188 | IVVD | Invivyd, Inc. | 690.87M | - | 1,806,292 | 50.04M |
| 189 | RGNX | REGENXBIO Inc. | 689.49M | - | 650,747 | 161.32M |
| 190 | PROK | ProKidney Corp. | 688.91M | - | 1,508,618 | 744.00K |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 680.31M | - | 275,827 | 282.08M |
| 192 | SLS | SELLAS Life Sciences Group, Inc. | 677.72M | 3.65% | 7,934,690 | - |
| 193 | JBIO | Jade Biosciences, Inc. | 676.26M | - | 271,861 | - |
| 194 | FULC | Fulcrum Therapeutics, Inc. | 668.94M | - | 1,275,463 | 80.00M |
| 195 | TENX | Tenax Therapeutics, Inc. | 651.15M | 0.94% | 165,816 | - |
| 196 | CGEM | Cullinan Therapeutics, Inc. | 633.30M | - | 600,613 | - |
| 197 | ENGN | enGene Holdings Inc. | 623.63M | - | 262,756 | - |
| 198 | VOR | Vor Biopharma Inc. | 609.84M | - | 980,898 | - |
| 199 | DRTS | Alpha Tau Medical Ltd. | 607.08M | - | 370,532 | - |
| 200 | CRVS | Corvus Pharmaceuticals, Inc. | 601.19M | 12.75% | 3,147,006 | - |
| 201 | MGTX | MeiraGTx Holdings plc | 597.24M | - | 748,919 | 27.42M |
| 202 | FBRX | Forte Biosciences, Inc. | 594.32M | -0.18% | 125,572 | - |
| 203 | GOSS | Gossamer Bio, Inc. | 583.27M | - | 3,871,325 | 44.05M |
| 204 | KROS | Keros Therapeutics, Inc. | 574.59M | - | 335,405 | 246.72M |
| 205 | LENZ | LENZ Therapeutics, Inc. | 572.29M | 0.83% | 1,254,844 | 17.50M |
| 206 | REPL | Replimune Group, Inc. | 552.24M | - | 2,942,720 | - |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 542.79M | - | 902,093 | 180.61M |
| 208 | LXEO | Lexeo Therapeutics, Inc. | 539.38M | -1.47% | 1,026,363 | - |
| 209 | CRMD | CorMedix Inc. | 534.19M | - | 2,889,627 | 214.30M |
| 210 | ANRO | Alto Neuroscience, Inc. | 533.41M | - | 206,782 | - |
| 211 | EVMN | Evommune, Inc. | 529.60M | - | 192,586 | 13.00M |
| 212 | DSGN | Design Therapeutics, Inc. | 528.62M | - | 234,089 | - |
| 213 | OCGN | Ocugen, Inc. | 527.82M | - | 8,193,408 | 5.37M |
| 214 | VSTM | Verastem, Inc. | 515.57M | - | 2,046,273 | 13.38M |
| 215 | LBRX | LB Pharmaceuticals Inc | 505.22M | - | 258,589 | - |
| 216 | LYEL | Lyell Immunopharma, Inc. | 504.76M | - | 152,243 | 41.00K |
| 217 | PRTA | Prothena Corporation plc | 503.31M | - | 761,486 | 11.79M |
| 218 | ZVRA | Zevra Therapeutics, Inc. | 502.74M | -1.00% | 747,097 | 84.39M |
| 219 | LXRX | Lexicon Pharmaceuticals, Inc. | 497.86M | - | 2,908,065 | 70.86M |
| 220 | NAGE | Niagen Bioscience, Inc. | 495.75M | -1.90% | 730,843 | 124.71M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 477.60M | - | 571,729 | - |
| 222 | MNPR | Monopar Therapeutics Inc. | 467.78M | - | 301,552 | - |
| 223 | ASMB | Assembly Biosciences, Inc. | 464.55M | - | 131,370 | 37.19M |
| 224 | ALT | Altimmune, Inc. | 462.82M | - | 2,596,157 | 20.00K |
| 225 | ABSI | Absci Corporation | 454.12M | -0.98% | 2,729,098 | 2.82M |
| 226 | BCYC | Bicycle Therapeutics plc | 451.59M | - | 329,020 | 28.34M |
| 227 | ADCT | ADC Therapeutics SA | 448.44M | - | 754,248 | 75.21M |
| 228 | AVXL | Anavex Life Sciences Corp. | 447.63M | - | 1,735,973 | - |
| 229 | VTVT | vTv Therapeutics Inc. | 441.63M | - | 22,321 | 17.00K |
| 230 | VNDA | Vanda Pharmaceuticals Inc. | 441.45M | 0.27% | 864,636 | 212.07M |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.09M | - | 144,648 | - |
| 232 | PRTC | PureTech Health plc | 435.60M | - | 8,698 | 6.39M |
| 233 | FDMT | 4D Molecular Therapeutics, Inc. | 431.37M | - | 754,694 | 120.00K |
| 234 | NBP | NovaBridge Biosciences | 430.04M | - | 691,497 | - |
| 235 | CTNM | Contineum Therapeutics, Inc. | 428.86M | - | 269,372 | - |
| 236 | SLDB | Solid Biosciences Inc. | 426.17M | - | 905,727 | - |
| 237 | IMMP | Immutep Limited | 415.52M | - | 128,976 | 3.31M |
| 238 | LCTX | Lineage Cell Therapeutics, Inc. | 411.96M | - | 1,467,753 | 10.82M |
| 239 | DMAC | DiaMedica Therapeutics Inc. | 405.86M | - | 614,875 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 395.51M | - | 113,308 | - |
| 241 | TRDA | Entrada Therapeutics, Inc. | 394.48M | 1.66% | 299,090 | 61.52M |
| 242 | RCKT | Rocket Pharmaceuticals, Inc. | 393.93M | -1.89% | 3,225,708 | - |
| 243 | HELP | Cybin Inc. | 386.25M | - | 303,273 | - |
| 244 | AUTL | Autolus Therapeutics plc | 367.28M | - | 1,911,201 | 51.13M |
| 245 | ALLO | Allogene Therapeutics, Inc. | 366.31M | - | 4,728,459 | 22.00K |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 363.96M | - | 341,182 | 65.32M |
| 247 | PEPG | PepGen Inc. | 357.49M | - | 768,486 | - |
| 248 | FHTX | Foghorn Therapeutics Inc. | 352.66M | - | 159,454 | 24.52M |
| 249 | TECX | Tectonic Therapeutic, Inc. | 351.87M | - | 305,603 | - |
| 250 | CADL | Candel Therapeutics, Inc. | 351.35M | 7.74% | 1,226,588 | - |
| 251 | ACIU | AC Immune SA | 347.29M | - | 198,365 | 5.48M |
| 252 | GLSI | Greenwich LifeSciences, Inc. | 344.70M | - | 974,183 | - |
| 253 | NMRA | Neumora Therapeutics, Inc. | 343.28M | - | 1,369,424 | - |
| 254 | AARD | Aardvark Therapeutics, Inc. | 334.66M | - | 136,451 | - |
| 255 | XOMA | XOMA Royalty Corporation | 326.54M | - | 1,213,862 | 47.11M |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 322.64M | -0.27% | 269,968 | 33.98M |
| 257 | PBYI | Puma Biotechnology, Inc. | 320.99M | - | 247,552 | 212.00M |
| 258 | AURA | Aura Biosciences, Inc. | 318.79M | - | 157,759 | - |
| 259 | ZURA | Zura Bio Limited | 312.76M | - | 2,166,946 | - |
| 260 | ACHV | Achieve Life Sciences, Inc. | 310.35M | - | 1,253,822 | - |
| 261 | CLLS | Cellectis S.A. | 300.20M | - | 72,883 | 82.55M |
| 262 | IMRX | Immuneering Corporation | 295.73M | - | 1,572,683 | - |
| 263 | STTK | Shattuck Labs, Inc. | 293.62M | - | 485,596 | 1.00M |
| 264 | CAMP | Camp4 Therapeutics Corporation | 291.05M | -0.18% | 105,175 | 3.80M |
| 265 | ABEO | Abeona Therapeutics Inc. | 284.50M | - | 2,150,401 | 400.00K |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 283.86M | - | 763,829 | 15.74M |
| 267 | AVTX | Avalo Therapeutics, Inc. | 278.80M | - | 358,391 | 192.00K |
| 268 | ALDX | Aldeyra Therapeutics, Inc. | 278.55M | - | 1,634,892 | - |
| 269 | RLMD | Relmada Therapeutics, Inc. | 274.27M | - | 541,562 | - |
| 270 | OABI | OmniAb, Inc. | 273.52M | - | 452,106 | 21.09M |
| 271 | HRTX | Heron Therapeutics, Inc. | 273.21M | - | 808,538 | 155.10M |
| 272 | NGNE | Neurogene Inc. | 271.85M | - | 90,699 | 925.00K |
| 273 | TARA | Protara Therapeutics, Inc. | 268.47M | - | 1,172,347 | - |
| 274 | LRMR | Larimar Therapeutics, Inc. | 267.90M | -3.99% | 1,614,435 | - |
| 275 | AVIR | Atea Pharmaceuticals, Inc. | 265.63M | - | 347,851 | - |
| 276 | CBIO | Crescent Biopharma, Inc. | 264.12M | - | 169,450 | - |
| 277 | GUTS | Fractyl Health, Inc. | 261.75M | - | 2,529,822 | 3.00K |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 259.23M | - | 93,338 | 38.79M |
| 279 | MENS | Jyong Biotech Ltd. | 256.08M | - | 411,597 | - |
| 280 | RZLT | Rezolute, Inc. | 253.15M | - | 4,379,011 | - |
| 281 | NAUT | Nautilus Biotechnology, Inc. | 252.61M | - | 453,639 | - |
| 282 | IMMX | Immix Biopharma, Inc. | 247.67M | - | 719,679 | - |
| 283 | PALI | Palisade Bio, Inc. | 247.35M | -5.14% | 9,869,828 | - |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 238.28M | - | 136,915 | 2.82M |
| 285 | SLN | Silence Therapeutics plc | 238.06M | - | 312,272 | 25.83M |
| 286 | ARMP | Armata Pharmaceuticals, Inc. | 233.00M | - | 55,979 | 5.05M |
| 287 | IKT | Inhibikase Therapeutics, Inc. | 228.43M | - | 319,026 | 1.00 |
| 288 | ENLV | Enlivex Therapeutics Ltd. | 223.14M | - | 383,555 | - |
| 289 | CGEN | Compugen Ltd. | 220.74M | - | 1,060,705 | 6.90M |
| 290 | NVCT | Nuvectis Pharma, Inc. | 218.50M | 0.59% | 57,801 | - |
| 291 | CCCC | C4 Therapeutics, Inc. | 216.12M | - | 1,265,983 | 30.11M |
| 292 | HUMA | Humacyte, Inc. | 214.23M | - | 3,845,764 | 1.57M |
| 293 | TNXP | Tonix Pharmaceuticals Holding Corp. | 212.39M | - | 500,368 | 10.30M |
| 294 | CABA | Cabaletta Bio, Inc. | 211.78M | 5.77% | 1,902,135 | - |
| 295 | TLSA | Tiziana Life Sciences Ltd | 210.38M | 15.86% | 1,517,248 | - |
| 296 | VYGR | Voyager Therapeutics, Inc. | 209.06M | - | 569,623 | 31.32M |
| 297 | MDWD | MediWound Ltd. | 208.35M | - | 199,464 | 20.93M |
| 298 | MIST | Milestone Pharmaceuticals Inc. | 208.24M | - | 2,587,938 | - |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 207.14M | -4.20% | 419,684 | 97.60M |
| 300 | OVID | Ovid Therapeutics Inc. | 204.39M | - | 835,309 | 6.61M |
| 301 | CLYM | Climb Bio, Inc. | 201.48M | - | 693,907 | - |
| 302 | ALEC | Alector, Inc. | 200.84M | - | 1,205,141 | 69.05M |
| 303 | SGMT | Sagimet Biosciences Inc. | 199.68M | - | 423,055 | - |
| 304 | EDIT | Editas Medicine, Inc. | 198.17M | - | 2,200,567 | 46.38M |
| 305 | QNCX | Quince Therapeutics, Inc. | 197.67M | 23.26% | 2,857,072 | - |
| 306 | GALT | Galectin Therapeutics Inc. | 196.00M | - | 514,911 | - |
| 307 | CRDF | Cardiff Oncology, Inc. | 194.00M | - | 771,711 | 501.00K |
| 308 | SLGL | Sol-Gel Technologies Ltd. | 193.61M | 1.74% | 9,023 | 18.97M |
| 309 | CHRS | Coherus Oncology, Inc. | 193.39M | - | 985,179 | 277.73M |
| 310 | RNAC | Cartesian Therapeutics, Inc. | 192.95M | - | 149,256 | 1.09M |
| 311 | NERV | Minerva Neurosciences, Inc. | 192.57M | - | 34,950 | - |
| 312 | ZNTL | Zentalis Pharmaceuticals, Inc. | 191.66M | - | 1,200,950 | 26.87M |
| 313 | SABS | SAB Biotherapeutics, Inc. | 189.48M | - | 733,647 | 114.70K |
| 314 | IPSC | Century Therapeutics, Inc. | 189.47M | - | 870,868 | 113.34M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 182.16M | - | 111,533 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 173.82M | - | 603,075 | 18.86M |
| 317 | SRZN | Surrozen, Inc. | 171.43M | - | 45,010 | 3.60M |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 170.01M | - | 77,220 | 59.99K |
| 319 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | - | 1,390,607 | 1.20M |
| 320 | VXRT | Vaxart, Inc. | 168.39M | 7.95% | 1,572,642 | 148.20M |
| 321 | ELDN | Eledon Pharmaceuticals, Inc. | 168.23M | - | 1,037,852 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 164.06M | - | 404,248 | 61.84M |
| 323 | IPHA | Innate Pharma S.A. | 163.64M | - | 43,777 | 14.84M |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 157.94M | -1.03% | 3,688,800 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.16M | - | 157,875 | - |
| 326 | CDXS | Codexis, Inc. | 150.84M | - | 441,838 | 52.93M |
| 327 | PRLD | Prelude Therapeutics Incorporated | 149.14M | - | 1,443,687 | 10.50M |
| 328 | ORMP | Oramed Pharmaceuticals Inc. | 146.47M | - | 320,899 | 2.00M |
| 329 | BDTX | Black Diamond Therapeutics, Inc. | 145.86M | - | 1,423,426 | 70.00M |
| 330 | MOLN | Molecular Partners AG | 145.01M | - | 1,442 | 856.30K |
| 331 | NKTX | Nkarta, Inc. | 144.90M | 4.08% | 964,987 | - |
| 332 | IRD | Opus Genetics, Inc. | 144.82M | - | 213,313 | 14.63M |
| 333 | MCRB | Seres Therapeutics, Inc. | 144.38M | - | 46,000 | 351.00K |
| 334 | ELTX | Elicio Therapeutics, Inc. | 144.34M | 0.12% | 137,306 | - |
| 335 | FATE | Fate Therapeutics, Inc. | 137.27M | - | 5,159,185 | 7.14M |
| 336 | WHWK | Whitehawk Therapeutics, Inc. | 137.14M | - | 150,827 | 14.38M |
| 337 | CRBU | Caribou Biosciences, Inc. | 136.46M | - | 2,635,579 | 9.30M |
| 338 | SPRO | Spero Therapeutics, Inc. | 135.78M | - | 265,748 | 40.55M |
| 339 | SGMO | Sangamo Therapeutics, Inc. | 135.07M | - | 7,392,488 | 32.88M |
| 340 | ACTU | Actuate Therapeutics, Inc. | 134.70M | 1.85% | 44,901 | - |
| 341 | TTRX | Turn Therapeutics Inc. | 134.27M | - | 29,233 | - |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 133.03M | - | 582,307 | - |
| 343 | CNTX | Context Therapeutics Inc. | 132.31M | - | 1,116,771 | - |
| 344 | CGTX | Cognition Therapeutics, Inc. | 128.88M | - | 1,253,170 | - |
| 345 | ACOG | Alpha Cognition Inc. | 124.36M | - | 90,169 | 7.43M |
| 346 | GNLX | Genelux Corporation | 121.34M | - | 402,379 | 8.00K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 120.75M | - | 125,447 | 762.00K |
| 348 | STRO | Sutro Biopharma, Inc. | 117.74M | 5.74% | 98,622 | 105.65M |
| 349 | VRCA | Verrica Pharmaceuticals Inc. | 116.09M | - | 393,577 | 30.83M |
| 350 | KPTI | Karyopharm Therapeutics Inc. | 115.54M | - | 398,571 | 142.53M |
| 351 | FBIO | Fortress Biotech, Inc. | 115.46M | - | 846,718 | 62.30M |
| 352 | ABOS | Acumen Pharmaceuticals, Inc. | 114.48M | - | 305,677 | - |
| 353 | AGEN | Agenus Inc. | 113.59M | - | 1,738,937 | 106.83M |
| 354 | RPTX | Repare Therapeutics Inc. | 111.22M | - | 532,376 | 11.87M |
| 355 | PYXS | Pyxis Oncology, Inc. | 109.59M | -4.35% | 2,031,563 | 2.82M |
| 356 | THAR | Tharimmune, Inc. | 109.17M | - | 288,349 | - |
| 357 | MGNX | MacroGenics, Inc. | 108.80M | - | 1,295,552 | 127.63M |
| 358 | ONCY | Oncolytics Biotech Inc. | 108.68M | 3.80% | 1,907,188 | - |
| 359 | ARTV | Artiva Biotherapeutics, Inc. | 108.49M | - | 145,216 | 251.00K |
| 360 | ANIX | Anixa Biosciences, Inc. | 106.47M | - | 202,181 | - |
| 361 | SEER | Seer, Inc. | 106.32M | - | 121,550 | 16.38M |
| 362 | ETHZ | ETHZilla Corporation | 106.28M | - | 537,017 | 4.11M |
| 363 | INO | Inovio Pharmaceuticals, Inc. | 104.43M | -3.80% | 1,381,032 | 182.34K |
| 364 | CBUS | Cibus, Inc. | 103.02M | - | 280,074 | 3.79M |
| 365 | MREO | Mereo BioPharma Group plc | 101.84M | - | 14,336,355 | 500.00K |
| 366 | CSBR | Champions Oncology, Inc. | 100.12M | - | 4,389 | 58.42M |
| 367 | BMEA | Biomea Fusion, Inc. | 99.69M | - | 1,584,553 | - |
| 368 | SAVA | Cassava Sciences, Inc. | 98.55M | - | 1,176,334 | - |
| 369 | DTIL | Precision BioSciences, Inc. | 97.49M | - | 199,101 | 698.00K |
| 370 | HYFT | MindWalk Holdings Corp. | 96.65M | 3.50% | 654,637 | 19.02M |
| 371 | VANI | Vivani Medical, Inc. | 92.65M | - | 75,554 | - |
| 372 | ADAG | Adagene Inc. | 92.38M | - | 53,800 | 103.20K |
| 373 | COYA | Coya Therapeutics, Inc. | 89.56M | - | 385,311 | 3.99M |
| 374 | DWTX | Dogwood Therapeutics, Inc. | 89.19M | - | 29,471 | - |
| 375 | EXOZ | eXoZymes, Inc. | 88.29M | - | 12,359 | -700.00 |
| 376 | ACET | Adicet Bio, Inc. | 83.68M | - | 137,948 | - |
| 377 | OKYO | OKYO Pharma Limited | 83.12M | - | 184,575 | - |
| 378 | KRRO | Korro Bio, Inc. | 82.68M | - | 124,599 | 7.37M |
| 379 | ATOS | Atossa Therapeutics, Inc. | 79.44M | 6.02% | 11,640,906 | - |
| 380 | PLRX | Pliant Therapeutics, Inc. | 79.27M | - | 589,948 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 78.70M | - | 22,913 | 697.00K |
| 382 | MNOV | MediciNova, Inc. | 78.63M | - | 71,490 | 257.92K |
| 383 | XBIT | XBiotech Inc. | 78.35M | - | 9,314 | - |
| 384 | KZIA | Kazia Therapeutics Limited | 78.02M | - | 190,391 | 1.20M |
| 385 | ANVS | Annovis Bio, Inc. | 76.59M | - | 835,506 | - |
| 386 | IMUX | Immunic, Inc. | 74.34M | - | 1,363,515 | - |
| 387 | ENTX | Entera Bio Ltd. | 74.29M | - | 137,088 | 124.00K |
| 388 | CALC | CalciMedica, Inc. | 73.92M | - | 26,956 | - |
| 389 | PYPD | PolyPid Ltd. | 72.86M | 0.23% | 57,168 | - |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 71.97M | - | 76,479 | 501.00K |
| 391 | PTHS | Pelthos Therapeutics Inc. | 71.18M | - | 16,964 | 7.41M |
| 392 | BYSI | BeyondSpring Inc. | 70.32M | - | 15,255 | 1.88M |
| 393 | EQ | Equillium, Inc. | 70.03M | - | 531,612 | 4.39M |
| 394 | GANX | Gain Therapeutics, Inc. | 69.62M | - | 1,856,356 | - |
| 395 | IMA | ImageneBio, Inc. | 69.55M | - | 7,794 | 800.00K |
| 396 | ATYR | aTyr Pharma, Inc. | 69.43M | - | 1,252,321 | 190.00K |
| 397 | IFRX | InflaRx N.V. | 67.75M | - | 490,634 | 73.73K |
| 398 | TVGN | Tevogen Bio Holdings Inc. | 67.70M | - | 223,729 | - |
| 399 | CRVO | CervoMed Inc. | 67.36M | - | 76,314 | 6.16M |
| 400 | NRXP | NRx Pharmaceuticals, Inc. | 67.20M | - | 1,503,249 | 242.00K |
| 401 | MAIA | MAIA Biotechnology, Inc. | 66.58M | - | 2,413,693 | - |
| 402 | ANL | Adlai Nortye Ltd. | 66.42M | - | 112,308 | -1.35M |
| 403 | TCRX | TScan Therapeutics, Inc. | 64.13M | - | 654,440 | 8.42M |
| 404 | ALXO | ALX Oncology Holdings Inc. | 63.44M | - | 204,477 | - |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 62.48M | 5.88% | 2,018,921 | - |
| 406 | MGX | Metagenomi Therapeutics, Inc. | 62.33M | - | 199,056 | 30.91M |
| 407 | LPCN | Lipocine Inc. | 61.79M | - | 244,854 | 4.32M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 60.13M | - | 227,324 | - |
| 409 | ATHE | Alterity Therapeutics Limited | 58.41M | - | 13,212 | 3.57M |
| 410 | ICCC | ImmuCell Corporation | 57.53M | - | 40,914 | 27.77M |
| 411 | RADX | Radiopharm Theranostics Limited | 57.10M | - | 25,108 | 8.20M |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.48M | - | 54,368 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 56.14M | - | 4,176 | - |
| 414 | NTRB | Nutriband Inc. | 53.00M | - | 9,962 | 2.28M |
| 415 | LITS | Lite Strategy, Inc. | 52.58M | - | 461,662 | - |
| 416 | PDSB | PDS Biotechnology Corporation | 52.06M | - | 530,028 | - |
| 417 | OSTX | OS Therapies Incorporated | 51.41M | - | 424,158 | - |
| 418 | PSTV | Plus Therapeutics, Inc. | 50.91M | 3.12% | 20,772,175 | 5.26M |
| 419 | IBIO | iBio, Inc. | 49.47M | - | 888,362 | 500.00K |
| 420 | ALGS | Aligos Therapeutics, Inc. | 48.86M | - | 65,988 | 2.65M |
| 421 | NRXS | NeurAxis, Inc. | 48.68M | - | 46,344 | 3.36M |
| 422 | TIL | Instil Bio, Inc. | 47.95M | - | 74,826 | - |
| 423 | ABVC | ABVC BioPharma, Inc. | 47.85M | 0.50% | 43,233 | 797.92K |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 47.79M | - | 150,666 | - |
| 425 | IBO | Impact BioMedical Inc. | 47.24M | - | 39,928 | 25.00K |
| 426 | HURA | TuHURA Biosciences, Inc. | 46.18M | 0.01% | 274,401 | - |
| 427 | INMB | INmune Bio, Inc. | 45.99M | - | 394,333 | 50.00K |
| 428 | KZR | Kezar Life Sciences, Inc. | 45.40M | - | 14,411 | - |
| 429 | NXTC | NextCure, Inc. | 45.26M | - | 30,160 | - |
| 430 | ANEB | Anebulo Pharmaceuticals, Inc. | 44.78M | - | 105,706 | - |
| 431 | APLM | Apollomics, Inc. | 44.53M | - | 4,475 | 6.93M |
| 432 | QTTB | Q32 Bio Inc. | 44.30M | - | 105,787 | - |
| 433 | CVM | CEL-SCI Corporation | 43.31M | - | 78,778 | - |
| 434 | XLO | Xilio Therapeutics, Inc. | 43.23M | - | 132,882 | 31.80M |
| 435 | VERU | Veru Inc. | 43.18M | - | 263,189 | 16.89M |
| 436 | TVRD | Tvardi Therapeutics, Inc. | 42.87M | - | 30,954 | - |
| 437 | JSPR | Jasper Therapeutics, Inc. | 42.82M | - | 301,380 | - |
| 438 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 42.04M | 2.68% | 4,872,394 | - |
| 439 | ESLA | Estrella Immunopharma, Inc. | 41.78M | - | 124,801 | - |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 41.49M | - | 75,320 | 90.00K |
| 441 | PASG | Passage Bio, Inc. | 40.91M | - | 40,317 | - |
| 442 | OKUR | OnKure Therapeutics, Inc. | 40.64M | - | 24,642 | - |
| 443 | CING | Cingulate Inc. | 40.30M | - | 206,298 | - |
| 444 | GLTO | Galecto, Inc. | 39.89M | - | 34,105 | - |
| 445 | XCUR | Exicure, Inc. | 39.65M | - | 43,094 | 500.00K |
| 446 | LTRN | Lantern Pharma Inc. | 38.25M | - | 46,219 | - |
| 447 | EVAX | Evaxion A/S | 37.95M | - | 94,172 | 7.65M |
| 448 | GBIO | Generation Bio Co. | 37.93M | - | 98,827 | 15.27M |
| 449 | CELU | Celularity Inc. | 37.78M | - | 27,519 | 40.58M |
| 450 | RNXT | RenovoRx, Inc. | 37.38M | - | 152,671 | 928.00K |
| 451 | KYNB | Kyntra Bio, Inc. | 36.98M | - | 11,571 | 8.30M |
| 452 | IOBT | IO Biotech, Inc. | 36.13M | - | 436,484 | - |
| 453 | OTLK | Outlook Therapeutics, Inc. | 35.02M | 4.60% | 2,045,652 | 1.41M |
| 454 | SER | Serina Therapeutics, Inc. | 33.06M | - | 156,613 | 116.00K |
| 455 | ANTX | AN2 Therapeutics, Inc. | 32.88M | - | 21,936 | - |
| 456 | ATRA | Atara Biotherapeutics, Inc. | 32.73M | - | 509,376 | 151.93M |
| 457 | SKYE | Skye Bioscience, Inc. | 32.06M | - | 254,375 | - |
| 458 | RNTX | Rein Therapeutics Inc. | 31.81M | - | 97,328 | - |
| 459 | DYAI | Dyadic International, Inc. | 31.49M | - | 14,963 | 3.34M |
| 460 | BCTX | BriaCell Therapeutics Corp. | 31.07M | - | 755,607 | - |
| 461 | GNTA | Genenta Science S.p.A. | 30.46M | - | 80,768 | - |
| 462 | MRKR | Marker Therapeutics, Inc. | 30.18M | - | 235,050 | 4.69M |
| 463 | PLUR | Pluri Inc. | 29.71M | - | 13,018 | 1.33M |
| 464 | BRNS | Barinthus Biotherapeutics plc | 29.61M | - | 23,309 | 14.97M |
| 465 | JUNS | Jupiter Neurosciences, Inc. | 29.56M | - | 57,667 | - |
| 466 | LIXT | Lixte Biotechnology Holdings, Inc. | 28.92M | - | 140,410 | - |
| 467 | PTN | Palatin Technologies, Inc. | 28.83M | - | 39,546 | 8.85M |
| 468 | IGC | IGC Pharma, Inc. | 28.39M | - | 427,062 | 1.11M |
| 469 | NRSN | NeuroSense Therapeutics Ltd. | 28.22M | - | 103,757 | - |
| 470 | BOLD | Boundless Bio, Inc. | 27.76M | - | 32,025 | - |
| 471 | RLYB | Rallybio Corporation | 27.75M | - | 198,491 | 674.00K |
| 472 | DARE | Daré Bioscience, Inc. | 27.58M | - | 62,105 | -57.13K |
| 473 | CUE | Cue Biopharma, Inc. | 27.55M | - | 1,314,034 | 7.10M |
| 474 | QNTM | Quantum BioPharma Ltd. | 27.54M | - | 28,085 | - |
| 475 | HYPD | Hyperion DeFi, Inc. | 27.38M | - | 214,197 | 345.32K |
| 476 | SNTI | Senti Biosciences, Inc. | 27.08M | - | 181,816 | - |
| 477 | HOWL | Werewolf Therapeutics, Inc. | 26.66M | - | 571,276 | 1.14M |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 26.22M | -1.07% | 1,169,839 | 721.00K |
| 479 | NNVC | NanoViricides, Inc. | 25.45M | - | 256,437 | - |
| 480 | PLRZ | Polyrizon Ltd. | 24.79M | - | 51,194 | - |
| 481 | INTS | Intensity Therapeutics, Inc. | 24.52M | -2.34% | 761,112 | - |
| 482 | KLTO | Klotho Neurosciences, Inc. | 24.12M | - | 440,512 | - |
| 483 | LONA | LeonaBio, Inc. | 24.06M | - | 77,918 | - |
| 484 | FBLG | FibroBiologics, Inc. | 22.28M | -0.77% | 567,887 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 22.21M | 0.49% | 55,838 | 15.65M |
| 486 | LNAI | Lunai Bioworks Inc. | 21.68M | - | 76,014 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 21.38M | - | 86,444 | - |
| 488 | LIMN | Liminatus Pharma, Inc. | 20.82M | - | 60,916 | - |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.49M | - | 51,077 | - |
| 490 | BCAB | BioAtla, Inc. | 20.45M | - | 2,855,665 | 11.00M |
| 491 | CASI | CASI Pharmaceuticals, Inc. | 19.66M | - | 27,108 | 26.85M |
| 492 | OSRH | OSR Holdings, Inc. | 19.18M | - | 1,298,640 | -90.52K |
| 493 | CLGN | CollPlant Biotechnologies Ltd. | 19.16M | - | 8,898 | 2.48M |
| 494 | KALA | KALA BIO, Inc. | 19.07M | - | 4,494,762 | - |
| 495 | LSTA | Lisata Therapeutics, Inc. | 19.05M | - | 34,994 | 1.07M |
| 496 | LEXX | Lexaria Bioscience Corp. | 18.88M | - | 77,729 | 522.00K |
| 497 | VYNE | VYNE Therapeutics Inc. | 18.87M | - | 235,065 | 524.00K |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 18.40M | - | 45,617 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 18.17M | - | 47,920 | - |
| 500 | ITRM | Iterum Therapeutics plc | 17.98M | - | 295,316 | 390.00K |
| 501 | CTXR | Citius Pharmaceuticals, Inc. | 17.81M | - | 277,181 | - |
| 502 | PMN | ProMIS Neurosciences, Inc. | 17.61M | - | 9,256 | - |
| 503 | TRAW | Traws Pharma, Inc. | 16.14M | - | 986,822 | 2.85M |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.13M | - | 354,117 | - |
| 505 | COCP | Cocrystal Pharma, Inc. | 15.30M | - | 46,753 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.29M | - | 9,030,540 | 1.00M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 15.22M | - | 36,261 | - |
| 508 | BCDA | BioCardia, Inc. | 14.86M | - | 61,131 | 3.00K |
| 509 | SNGX | Soligenix, Inc. | 14.22M | - | 145,647 | 2.34K |
| 510 | NCNA | NuCana plc | 13.78M | - | 151,715 | - |
| 511 | AEON | AEON Biopharma, Inc. | 13.50M | - | 63,703 | - |
| 512 | TPST | Tempest Therapeutics, Inc. | 13.40M | - | 92,270 | - |
| 513 | GRDX | GridAI Technologies Corp. | 13.18M | - | 116,958 | - |
| 514 | SNSE | Sensei Biotherapeutics, Inc. | 13.17M | - | 74,872 | - |
| 515 | SYBX | Synlogic, Inc. | 13.10M | - | 5,246 | 8.00K |
| 516 | CRIS | Curis, Inc. | 12.87M | - | 574,534 | 11.65M |
| 517 | AKTX | Akari Therapeutics, Plc | 12.85M | 4.98% | 313,805 | - |
| 518 | MBRX | Moleculin Biotech, Inc. | 12.81M | - | 132,063 | - |
| 519 | BLRX | BioLineRx Ltd. | 12.41M | - | 48,858 | 12.74M |
| 520 | PHIO | Phio Pharmaceuticals Corp. | 12.27M | - | 135,802 | - |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 12.21M | - | 31,927 | 5.20M |
| 522 | EDSA | Edesa Biotech, Inc. | 12.17M | - | 11,550 | - |
| 523 | IMNN | Imunon, Inc. | 12.14M | - | 40,586 | - |
| 524 | LGVN | Longeveron Inc. | 11.78M | - | 78,851 | 1.44M |
| 525 | GDTC | CytoMed Therapeutics Limited | 11.00M | - | 51,523 | 573.19K |
| 526 | INAB | IN8bio, Inc. | 10.93M | - | 236,622 | - |
| 527 | NCEL | NewcelX Ltd. | 10.76M | - | 71,557 | - |
| 528 | CMMB | Chemomab Therapeutics Ltd. | 10.22M | - | 57,738 | - |
| 529 | BRTX | BioRestorative Therapies, Inc. | 10.21M | - | 15,211 | 383.40K |
| 530 | MTVA | MetaVia Inc. | 9.98M | - | 617,279 | - |
| 531 | PULM | Pulmatrix, Inc. | 9.59M | - | 16,977 | 3.00K |
| 532 | ABP | Abpro Holdings, Inc. | 9.51M | - | 7,139 | 183.00K |
| 533 | ERNA | Ernexa Therapeutics Inc. | 9.50M | - | 30,536 | 1,000.00 |
| 534 | APVO | Aptevo Therapeutics Inc. | 9.42M | - | 77,577 | - |
| 535 | ICU | SeaStar Medical Holding Corporation | 9.12M | - | 71,572 | 881.00K |
| 536 | EVGN | Evogene Ltd. | 9.11M | - | 17,541 | 8.02M |
| 537 | BIVI | BioVie Inc. | 9.08M | 2.12% | 97,722 | - |
| 538 | PMCB | PharmaCyte Biotech, Inc. | 9.02M | - | 172,205 | - |
| 539 | ALZN | Alzamend Neuro, Inc. | 8.93M | - | 83,965 | - |
| 540 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.62M | - | 45,629 | - |
| 541 | IMRN | Immuron Limited | 8.52M | - | 54,192 | 4.78M |
| 542 | XTLB | XTL Biopharmaceuticals Ltd. | 8.40M | - | 337,379 | 968.00K |
| 543 | APM | Aptorum Group Limited | 8.39M | - | 17,759 | - |
| 544 | RNAZ | TransCode Therapeutics, Inc. | 8.20M | - | 5,314 | - |
| 545 | PCSA | Processa Pharmaceuticals, Inc. | 8.02M | - | 85,553 | - |
| 546 | GTBP | GT Biopharma, Inc. | 7.93M | - | 2,055,130 | - |
| 547 | KPRX | Kiora Pharmaceuticals, Inc. | 7.92M | - | 3,777 | 20.00K |
| 548 | BGMS | Bio Green Med Solution, Inc. | 7.84M | - | 70,227 | 81.00K |
| 549 | ADXN | Addex Therapeutics Ltd | 7.75M | - | 4,473 | 198.82K |
| 550 | MBIO | Mustang Bio, Inc. | 7.66M | - | 16,994 | - |
| 551 | CLDI | Calidi Biotherapeutics, Inc. | 7.54M | - | 120,783 | - |
| 552 | SLXN | Silexion Therapeutics Corp | 7.10M | - | 38,364 | - |
| 553 | PPBT | Purple Biotech Ltd | 7.07M | - | 83,285 | - |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 6.99M | - | 267,667 | 6.00K |
| 555 | TOVX | Theriva Biologics, Inc. | 6.96M | - | 4,257,833 | - |
| 556 | GNPX | Genprex, Inc. | 6.96M | -9.09% | 1,730,752 | - |
| 557 | TCRT | Alaunos Therapeutics, Inc. | 6.87M | - | 9,067 | 6.00K |
| 558 | JAGX | Jaguar Health, Inc. | 6.49M | 87.05% | 160,399,477 | 11.79M |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.28M | 0.84% | 48,353 | 488.24K |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.25M | - | 256,418 | - |
| 561 | ACXP | Acurx Pharmaceuticals, Inc. | 6.22M | - | 17,251 | - |
| 562 | INDP | Indaptus Therapeutics, Inc. | 6.01M | - | 237,739 | - |
| 563 | ASBP | Aspire Biopharma Holdings, Inc. | 5.94M | - | 1,196,988 | 1.94K |
| 564 | DCOY | Decoy Therapeutics Inc. | 5.81M | - | 462,316 | - |
| 565 | CANF | Can-Fite BioPharma Ltd. | 5.64M | -6.54% | 69,084 | 560.00K |
| 566 | REVB | Revelation Biosciences, Inc. | 5.62M | - | 76,864 | - |
| 567 | XBIO | Xenetic Biosciences, Inc. | 5.54M | - | 81,732 | 2.86M |
| 568 | VIVS | VivoSim Labs, Inc. | 5.45M | - | 89,419 | 140.00K |
| 569 | CYCN | Cyclerion Therapeutics, Inc. | 5.18M | - | 83,310 | 2.86M |
| 570 | GOVX | GeoVax Labs, Inc. | 5.14M | - | 238,180 | 3.35M |
| 571 | SILO | Silo Pharma, Inc. | 5.03M | - | 125,795 | 72.10K |
| 572 | MTNB | Matinas BioPharma Holdings, Inc. | 4.42M | - | 36,203 | - |
| 573 | CNSP | CNS Pharmaceuticals, Inc. | 4.37M | - | 67,549 | - |
| 574 | PBM | Psyence Biomedical Ltd. | 4.28M | - | 81,091 | - |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 4.23M | - | 80,028 | - |
| 576 | PPCB | Propanc Biopharma, Inc. | 4.19M | - | 274,494 | - |
| 577 | PHGE | BiomX Inc. | 4.09M | - | 20,233 | - |
| 578 | XRTX | XORTX Therapeutics Inc. | 4.02M | 0.90% | 15,893 | - |
| 579 | ENVB | Enveric Biosciences, Inc. | 4.01M | - | 28,043 | - |
| 580 | OGEN | Oragenics, Inc. | 3.96M | - | 30,284 | - |
| 581 | CMND | Clearmind Medicine Inc. | 3.75M | - | 49,896 | - |
| 582 | HCWB | HCW Biologics Inc. | 3.73M | - | 232,676 | 422.03K |
| 583 | LYRA | Lyra Therapeutics, Inc. | 3.53M | - | 42,620 | 600.00K |
| 584 | AZTR | Azitra, Inc. | 3.52M | - | 4,275,224 | 7.50K |
| 585 | SPRC | SciSparc Ltd. | 3.51M | - | 357,435 | 1.31M |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.45M | - | 107,448 | - |
| 587 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.31M | - | 85,621 | 15.78K |
| 588 | BBLG | Bone Biologics Corporation | 3.20M | - | 142,827 | - |
| 589 | GRI | GRI Bio, Inc. | 3.10M | -7.60% | 1,029,161 | - |
| 590 | ENSC | Ensysce Biosciences, Inc. | 3.06M | -6.46% | 108,066 | 4.49M |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 3.00M | - | 27,810 | 1.15M |
| 592 | DRMA | Dermata Therapeutics, Inc. | 2.70M | - | 483,135 | - |
| 593 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.58M | - | 823,332 | 1.36M |
| 594 | ONCO | Onconetix, Inc. | 2.53M | - | 14,662 | 1.22M |
| 595 | CDT | CDT Equity Inc. | 2.47M | 5.19% | 2,524,005 | - |
| 596 | VRAX | Virax Biolabs Group Limited | 2.27M | -2.55% | 588,777 | 2.99K |
| 597 | BDRX | Biodexa Pharmaceuticals Plc | 1.88M | 3.23% | 1,218,751 | 104.90K |
| 598 | ADTX | Aditxt, Inc. | 1.55M | - | 4,088,312 | 5.95K |
| 599 | MLEC | Moolec Science SA | 1.35M | - | 599,118 | 7.83M |
| 600 | ELAB | PMGC Holdings Inc. | 591.58K | - | 378,406 | 285.95K |